{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:52:45Z","timestamp":1779281565752,"version":"3.51.4"},"reference-count":35,"publisher":"Baishideng Publishing Group Inc.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2004]]},"DOI":"10.3748\/wjg.v10.i10.1409","type":"journal-article","created":{"date-parts":[[2015,11,28]],"date-time":"2015-11-28T07:09:03Z","timestamp":1448694543000},"page":"1409","source":"Crossref","is-referenced-by-count":17,"title":["Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis"],"prefix":"10.3748","volume":"10","author":[{"given":"Xin","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.13.965"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0185(20000615)261:3&lt;126::AID-AR7&gt;3.0.CO;2-4"},{"key":"ref3","unstructured":"Kim CW, Lee HM, Lee TH, Kang C, Kleinman HK, Gho YS. Extracellular membrane vesicles from tumor cells promote angiogenesis <italic>via<\/italic> sphingomyelin. Cancer Res 2002;62:6312-6317."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.0991"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/104303401750270959"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2002.2075"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.8.1063"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112274200"},{"key":"ref9","unstructured":"Zhang M, Wang L, Wang HW, Pan X, Pan W, Qi ZT. [Effect of N-terminal deletion on biological activity of vascular endothelial cell growth inhibitor]. Shengwu Huaxue Yu Shengwu Wuli Xuebao (Shanghai) 2003;35:133-137."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/hh2401.101909"},{"key":"ref11","unstructured":"Tanaka T, Cao Y, Folkman J, Fine HA. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res 1998;58:3362-3369."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/104303401750476221"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-46817-4_40"},{"key":"ref14","unstructured":"Nguyen JT, Wu P, Clouse ME, Hlatky L, Terwilliger EF. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res 1998;58:5673-5677."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Cao GW, Qi ZT, Pan X, Zhang XQ, Miao XH, Feng Y, Lu XH, Kuriyama S, Du P. Gene therapy for human colorectal carcinoma using human CEA promoter contro led bacterial ADP-ribosylating toxin genes human CEA: PEA &amp; amp; DTA gene transfer. World J Gastroenterol 1998;4:388-391.","DOI":"10.3748\/wjg.v4.i5.388"},{"key":"ref16","unstructured":"Li Z, Pan X, Pan W, Cao GS, Wen ZZ, Fang GE, Qi ZT, Bi JW, Hua JD. Packaging and identification of recombinant adenovi-rus carrying endostatin-soluble vascular endothelial growth inhibitor gene. Shijie Huaren Xiaohua Zazhi 2003;11:741-744."},{"key":"ref17","unstructured":"Pan X, Li Z, Zhang M, Wang Y, Pan W, Qi ZT. Therapeutic effect of endostatin-vascular endothelial growth inhibitor re-combinant adenoviruses on gastric carcinoma in nude mice. Shijie Huaren Xiaohua Zazhi 2003;11:1282-1285."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-808"},{"key":"ref19","unstructured":"Michie J, Akudugu J, Binder A, Van Rensburg CE, B&ouml;hm L. Flow cytometric evaluation of apoptosis and cell viability as a criterion of anti-tumour drug toxicity. Anticancer Res 2003;23:2675-2679."},{"key":"ref20","unstructured":"Zhao CS, Zhang L, Shen YP. A preventive and therapeutic study of experimental corneal neovascularization. Tongji Yike Daxue Xuebao 1996;25:399-401."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14389"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.5991-5997.2000"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.6.1039"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000087641.56024.DA"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Seo K, Choi J, Park M, Rhee C. Angiogenesis effects of nerve growth factor (NGF) on rat corneas. J Vet Sci 2001;2:125-130.","DOI":"10.4142\/jvs.2001.2.2.125"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0757fje"},{"key":"ref27","unstructured":"N&ouml;r JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001;61:2183-2188."},{"key":"ref28","unstructured":"Olewniczak S, Chosia M, Kwas A, Kram A, Domaga\u0142a W. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women. Pol J Pathol 2002;53:183-188."},{"key":"ref29","unstructured":"Wang L, Pan W, Zhu FL, Jiao BH, Lou YH, Xiao Y, Qi ZT. Cloning, Expression and Biological Activity of VEGI(151), a Novel Vascular Endothelial Cell Growth Inhibitor. Shengwu Huaxue Yu Shengwu Wuli Xuebao (Shanghai) 2000;32:485-489."},{"key":"ref30","unstructured":"Cao MM, Pan W, Chen QL, Ma ZC, Ni ZJ, Wu XL, Wu WB, Pan X, Cao GW, Qi ZT. Construction of the eukaryotic expres-sion vector expressing the fusion protein of human endostatin protein and IL3 signal peptide. Shijie Huaren Xiaohua Zazhi 2001;9:43-46."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81848-6"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1&lt;131::AID-IJC22&gt;3.0.CO;2-O"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0595"},{"key":"ref34","unstructured":"Ding I, Sun JZ, Fenton B, Liu WM, Kimsely P, Okunieff P, Min W. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. Cancer Res 2001;61:526-531."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Zhai Y, Ni J, Jiang GW, Lu J, Xing L, Lincoln C, Carter KC, Janat F, Kozak D, Xu S. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas <italic>in vivo<\/italic>. FASEB J 1999;13:181-189.","DOI":"10.1096\/fasebj.13.1.181"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i10\/1409.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T21:20:51Z","timestamp":1567372851000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i10\/1409.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v10.i10.1409","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2004]]}}}